![Pierre Fabre Pharma Ducray Anacaps Reactiv Kapseln (30 Stk.) ab 17,16 € | Preisvergleich bei idealo.de Pierre Fabre Pharma Ducray Anacaps Reactiv Kapseln (30 Stk.) ab 17,16 € | Preisvergleich bei idealo.de](https://cdn.idealo.com/folder/Product/201764/1/201764139/s1_produktbild_gross/pierre-fabre-pharma-ducray-anacaps-reactiv-kapseln-30-stk.jpg)
Pierre Fabre Pharma Ducray Anacaps Reactiv Kapseln (30 Stk.) ab 17,16 € | Preisvergleich bei idealo.de
CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies | Pierre Fabre Pharma Norden AB
![Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News](https://www.eubusinessnews.com/wp-content/themes/wp-bootstrap-starter/aigm-image-handler/handler.gz?src=https%3A%2F%2Fwww.eubusinessnews.com%2Fwp-content%2Fuploads%2F2022%2F10%2FBormioli-Pharma.jpg&width=654&height=auto&format=webp)
Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News
![Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets](https://mma.prnewswire.com/media/1916090/Pierre_Fabre_Gennisium__Logo.jpg?p=twitter)